Peter Chu, PhD

Artificial intelligence (AI) is transforming how we approach RNA research and drug discovery. In this eBlog we review how data is one of the key pillars for the successful use of AI.

To support researchers as they generate RNA datasets, Eclipsebio is proud to announce the 2025 Data Catalyst Award. Winners of the award will obtain matching funds to cover the cost of generating their control datasets.

Precision oncology uses information on the patient's own tumor to create personalized therapies, such as RNA cancer vaccines. These therapies train a patient's own immune system to attack cancer.

Designing RNA sequences that are stable and efficiently translated is complex. AI-driven tools are unlocking new possibilities, enabling optimized RNA design to accelerate therapeutic development.